MILBEMAX CHEWABLE TABLETS FOR SMALL DOGS AND PUPPIES
국가: 포르투갈
언어: 영어
출처: HMA (Heads of Medicines Agencies)
환자 정보 전단 유효 성분:
milbemycin A<3>-oxim 2.5 mg, praziquantel 25 mg
제공처:
NOVARTIS SA
ATC 코드:
QP54AB51
약제 형태:
Chewable tablet
치료 그룹:
Milbemycin, combinations
치료 영역:
Dogs
승인 날짜:
2011-07-09
환자 정보 전단
SUMMARY OF PRODUCT CHARACTERISTICS
MILBEMAX chewable tablets for small dogs and puppies
Summary of Product Characteristics
Novartis Animal Health Inc.
CONFIDENTIAL
Page 2 of 7
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MILBEMAX chewable tablets for small dogs and puppies
SE: Milbemax vet. chewable tablets for small dogs and puppies
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One chewable tablet contains:
ACTIVE SUBSTANCES:
Milbemycin oxime
2.5 mg
Praziquantel
25.0 mg
EXCIPIENTS:
Glycerol (E422)
92.12 mg
Propylene glycol (E 1520)
0.91 mg
Iron oxide, brown (E 172)
0.66 mg
Butylhydroxyanisole (E 320)
0.26 mg
Propyl gallate (E 310)
0.09 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet
Oval shaped, dark brown.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In dogs : treatment of mixed infections by adult cestodes and nematodes of the following species:
- Cestodes:
_Dipylidium caninum _
_Taenia spp. _
_Echinococcus spp. _
_Mesocestoides spp. _
- Nematodes:
_Ancylostoma caninum _
_Toxocara canis _
_Toxascaris leonina _
_Trichuris vulpis _
_Crenosoma vulpis_ (Reduction of the level of infection)_ _
MILBEMAX chewable tablets for small dogs and puppies
Summary of Product Characteristics
Novartis Animal Health Inc.
CONFIDENTIAL
Page 3 of 7
_Angiostrongylus vasorum_ (Reduction of the level of infection) (see specific treatment schedule under
section 4.9 “Amounts to be administered and administration route”)_ _
_ _
The product can also be used in the preventi
전체 문서 읽기
제품 특성 요약
SUMMARY OF PRODUCT CHARACTERISTICS
MILBEMAX chewable tablets for small dogs and puppies
25-Sep-2009
Summary of Product Characteristics (MRP Day 85)
Novartis Animal Health Inc.
CONFIDENTIAL
Page 2 of 7
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MILBEMAX chewable tablet for small dogs and puppies
SE: Milbemax vet. chewable tablet for small dogs and puppies
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One chewable tablet contains:
ACTIVE SUBSTANCES:
Milbemycin oxime
2.5 mg
Praziquantel
25.0 mg
EXCIPIENTS:
Glycerol (E422)
92.12 mg
Propylene glycol (E 1520)
0.91 mg
Iron oxide, brown (E 172)
0.66 mg
Butylhydroxyanisole (E 320)
0.26 mg
Propyl gallate (E 310)
0.09 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet
Oval shaped, dark brown.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In dogs : treatment of mixed infections by adult cestodes and nematodes of the following species:
- Cestodes:
_Dipylidium caninum _
_Taenia spp. _
_Echinococcus spp. _
_Mesocestoides spp. _
- Nematodes:
_Ancylostoma caninum _
_Toxocara canis _
_Toxascaris leonina _
_Trichuris vulpis _
_Crenosoma vulpis_ (Reduction of the level of infection)_ _
MILBEMAX chewable tablets for small dogs and puppies
25-Sep-2009
Summary of Product Characteristics (MRP Day 85)
Novartis Animal Health Inc.
CONFIDENTIAL
Page 3 of 7
_Angiostrongylus vasorum_ (Reduction of the level of infection) (see specific treatment schedule under
section 4.9 “Amounts to be administered and administration route”)_ _
_ _
The
전체 문서 읽기
